Cargando…
PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430022/ http://dx.doi.org/10.1097/01.HS9.0000974556.83221.a1 |
_version_ | 1785090854160957440 |
---|---|
author | Shen, Yandong Freeman, Jane Kerridge, Ian Naidu, Kartik Holland, Juliette Mulligan, Stephen |
author_facet | Shen, Yandong Freeman, Jane Kerridge, Ian Naidu, Kartik Holland, Juliette Mulligan, Stephen |
author_sort | Shen, Yandong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104300222023-08-17 PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL Shen, Yandong Freeman, Jane Kerridge, Ian Naidu, Kartik Holland, Juliette Mulligan, Stephen Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430022/ http://dx.doi.org/10.1097/01.HS9.0000974556.83221.a1 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Shen, Yandong Freeman, Jane Kerridge, Ian Naidu, Kartik Holland, Juliette Mulligan, Stephen PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL |
title | PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL |
title_full | PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL |
title_fullStr | PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL |
title_full_unstemmed | PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL |
title_short | PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL |
title_sort | pb1934: measured optimum anti-spike level vaccination strategy and anti-viral access result in low covid hospitalisation and mortality in cll and mbl |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430022/ http://dx.doi.org/10.1097/01.HS9.0000974556.83221.a1 |
work_keys_str_mv | AT shenyandong pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl AT freemanjane pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl AT kerridgeian pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl AT naidukartik pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl AT hollandjuliette pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl AT mulliganstephen pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl |